|
ZXDB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.29900004273298E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.46800024861216E-10 |
| Normal-vs-Stage2 |
7.921400E-03 |
| Normal-vs-Stage3 |
2.720600E-01 |
| Normal-vs-Stage4 |
1.837170E-03 |
| Stage1-vs-Stage2 |
1.787370E-01 |
| Stage1-vs-Stage3 |
1.852050E-02 |
| Stage1-vs-Stage4 |
5.533800E-01 |
| Stage2-vs-Stage3 |
2.881400E-01 |
| Stage2-vs-Stage4 |
7.428400E-01 |
| Stage3-vs-Stage4 |
2.751400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.65959998258359E-09 |
| Normal-vs-AfricanAmerican |
2.80799999996528E-06 |
| Normal-vs-Asian |
4.839000E-03 |
| Caucasian-vs-AfricanAmerican |
7.563200E-01 |
| Caucasian-vs-Asian |
9.385200E-01 |
| AfricanAmerican-vs-Asian |
8.534000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.98410235095071E-11 |
| Normal-vs-Female |
2.448000E-02 |
| Male-vs-Female |
8.34450000000153E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.034140E-04 |
| Normal-vs-Extreme_Weight |
3.21390025703749E-10 |
| Normal-vs-Obese |
9.756300E-04 |
| Normal-vs-Extreme_Obese |
2.41799999999293E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.067380E-01 |
| Normal_Weight-vs-Obese |
4.182000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.977200E-01 |
| Extreme_Weight-vs-Obese |
5.900400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.245400E-01 |
| Obese-vs-Extreme_Obese |
1.093010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.819600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.45299999998461E-06 |
| Normal-vs-Age(61-80Yrs) |
1.11599951502228E-10 |
| Normal-vs-Age(81-100Yrs) |
2.40300000009519E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.643040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.544000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.694150E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.335700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.866200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.939800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.96419580389806E-11 |
| Normal-VS-Type2 PRCC |
2.49259999999252E-05 |
| Normal-VS-KIRP CIMP |
8.813200E-01 |
| Normal-VS-Unclassified PRCC |
2.282400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.979700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.135700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.264300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.728100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.336800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.104000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.35399996454333E-09 |
| Normal-vs-N1 |
8.177400E-01 |
| Normal-vs-N2 |
1.302230E-01 |
| N0-vs-N1 |
7.560200E-03 |
| N0-vs-N2 |
2.347200E-01 |
| N1-vs-N2 |
5.895400E-01 |
|
|
